Skip to content

The Effect of Water Intake on Glucose Regulation

The Effect of Water Intake on Glucose Regulation: A Pilot Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03765008
Acronym
INDIGO-I
Enrollment
0
Registered
2018-12-05
Start date
2019-02-11
Completion date
2019-04-29
Last updated
2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dehydration (Physiology), Glucose Metabolism Disorders, Water Deprivation

Keywords

water, vasopressin

Brief summary

There is a growing body of evidence suggesting low water intake and elevated levels of the hormone vasopressin exacerbate glucose regulation. This project will examine the physiological mechanism by which low water intake impairs glucose homeostasis. In the current proposal we aim to: 1) quantify the degree of glucose impairment as a response to elevated vasopressin due to low water intake and 2) identify the physiological mechanism by which elevated vasopressin, as a response to low water intake, impairs glucose regulation

Interventions

OTHERWater intake manipulation

for 5 days prior to each experiment subjects will undergo manipulation of their water intake.

Sponsors

Arizona State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
30 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

BMI 27.5-35

Exclusion criteria

* BMI \<27.5 or \>35 * high physical activity * diabetes * impaired liver or kidney function * cardiovascular disease * weight change of more than 3 kg in the past month * pregnancy * previous surgery on digestive tract (except appendectomy) * fluid balance will be exclusionary such as * serotonin re-uptake inhibitors.

Design outcomes

Primary

MeasureTime frameDescription
amount of glucose metabolized M220-240 min & 340-360 min of the protocolamount of glucose metabolized during the euglycemic & Hyperglycemic clamp
metabolic clearance rate for insulin220-240 min & 340-360 min of the protocolmetabolic clearance rate for insulin during the euglycemic & Hyperglycemic clamp
quantity of glucose metabolized per unit plasma insulin concentration220-240 min & 340-360 min of the protocolquantity of glucose metabolized per unit plasma insulin concentration during the euglycemic & Hyperglycemic clamp
Rate of glucose appearance & disappearance220-240 min & 340-360 min of the protocolRate of glucose appearance & disappearance during the euglycemic & Hyperglycemic clamp

Secondary

MeasureTime frameDescription
glucagon0 min, 240 min & 360 min of the protocolglucagon in response to water manipulation
Cortisol0 min, 240 min & 360 min of the protocolCortisol in response to water manipulation
Plasma copeptin0 min, 240 min & 360 min of the protocolPlasma copeptin in response to water manipulation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026